| Literature DB >> 7787496 |
Abstract
Glucagon is considered the drug of choice for treating bradycardia and hypotension encountered during beta-blocker poisoning. Its potential usefulness in reversing adverse effects encountered during therapeutic dosing with beta-blockers has not been well characterized. We present a case of sotalol-induced bradycardia reversed by glucagon.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7787496 PMCID: PMC2146520
Source DB: PubMed Journal: Can Fam Physician ISSN: 0008-350X Impact factor: 3.275